Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MELOXICAM vs MELPHALAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MELOXICAM vs MELPHALAN: Safety Overview

Metric MELOXICAM MELPHALAN
Total FAERS Reports 8,661 16,061
Deaths Reported 1,042 3,369
Death Rate 12.0% 21.0%
Hospitalizations 2,502 4,615
Average Patient Age 57.6 yrs 48.1 yrs
% Female Patients 72.7% 43.8%
FDA Approval Date Apr 13, 2000 Approved Prior to Jan 1, 1982
Manufacturer Exelan Pharmaceuticals Inc. Dr.Reddy's Laboratories Inc
Route ORAL INTRAVENOUS
Marketing Status Discontinued Discontinued